Cerebral to pay nearly $3.7M over controlled substance prescribing practices

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Novel LAA Closure Device ‘Promising’

PHOENIX — A novel transcatheter device that twists the left atrial appendage (LAA) closed from the inside appeared safe in first-in-human results. Among 15 atrial

June 9, 2023

Smaller Lesions, Better Baseline Visual Acuity Bode Well for Submacular Hemorrhage

Smaller submacular hemorrhages (SMHs) secondary to exudative age-related macular degeneration among patients with good baseline visual acuity (VA) have a better chance of improving and

September 26, 2023

Novo Holdings to purchase drug manufacturer Catalent for $16.5 billion, a deal that could expand Wegovy production

LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent in a $16.5 billion deal, an acquisition that will give

February 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.